METHODS OF USE – NASAL SPRAYS

 

Intranasal absorption of Delta(9)-tetrahydrocannabinol and WIN55,212-2 mesylate in rats.          (abst – 2007)                            http://www.ncbi.nlm.nih.gov/pubmed/17014999

 

Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.        (abst – 2010)                            http://www.ncbi.nlm.nih.gov/pubmed/20545522

 

Bioavailability of Δ⁹-tetrahydrocannabinol following intranasal administration of a

mucoadhesive gel spray delivery system in conscious rabbits.                       (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21244195

Share a link for